albumin binding comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 39-residue peptide | GIP-derived backbone with non-natural residues |
| Molar mass | Approximately 4.8 kDa | Peptide chain plus linker and lipid modifications |
| Appearance | White to off-white powder | Typical of lyophilized research material |
| Solubility | Soluble in water and aqueous buffer | Practically insoluble in nonpolar solvents |
| Storage temperature | Typically −20 °C for dry powder | Solutions usually held at 2–8 °C short term |
Identity and purity assessment of tirzepatide relies primarily on reversed-phase high-performance liquid chromatography coupled with ultraviolet detection. Mass spectrometry, often in electrospray ionization mode, confirms the molecular mass and detects sequence-related impurities. Peptide mapping after enzymatic digestion provides residue-level confirmation of the backbone. Each method addresses a different question: chromatography for purity and related substances, mass measurement for identity, and mapping for sequence fidelity. No single technique covers all three.
Research and analytical settings increasingly require documentation of peptide origin and chain of custody. Certificate of analysis documents typically report purity by chromatographic area, mass confirmation, appearance, and residual solvent or counterion content. Independent verification by an accredited laboratory is common when a material will be used in a regulated study. Open questions remain about how well compendial methods transfer between laboratories, and about which impurity thresholds are meaningful for materials not intended for clinical use.
Published work supports the view that engaging two incretin receptors produces changes in glucose handling and body weight larger than those seen with single-receptor activation. Why that difference arises is not fully settled. Open questions include how much of the observed weight effect depends on central versus peripheral signaling, and whether the two receptors form interacting complexes. Most reported findings come from controlled trials and animal models, and translation between species is imperfect. Further research is expected to refine these points over time.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its sequence is related to human glucose-dependent insulinotropic polypeptide, with modifications that include a C-terminal extension and a C20 fatty diacid joined through a linker. Those changes raise the molecule's affinity for serum albumin, which slows renal filtration and lengthens the time it stays in circulation. The free base has an average molecular mass near 4813.5 daltons. The compound is made by solid-phase peptide synthesis followed by chromatographic purification.
At the receptor level, tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Both belong to the class B family of G protein-coupled receptors and signal largely through cyclic AMP accumulation. The compound binds the two receptors with differing affinity, and the pattern of signaling at each site is described in the literature as biased rather than simply proportional to occupancy. Tissues carrying these receptors include pancreatic islets, adipose tissue, the central nervous system, and the gastrointestinal tract. The relative weight of each receptor population in producing metabolic effects continues to be studied.
Ochronosis is a medical condition characterized by the accumulation of homogentisic acid in connective tissues, leading to pigmentation changes. The term derives from the yellowish-brown (ocher-like) discoloration observed in histological samples. However, macroscopically, the affected tissues often appear bluish-grey due to the Tyndall effect, a phenomenon in which scattered light gives deeper-lying pigments a blue hue. Ochronosis is most commonly associated with the rare metabolic disorder alkaptonuria, a genetic condition involving homogentisic acid oxidase deficiency. It may also occur as an acquired condition, known as exogenous ochronosis, resulting from prolonged topical application or systemic exposure to certain phenol derivatives, particularly hydroquinone. The condition was first described by German pathologist Rudolf Virchow in 1865.
== Early life and education == Howard Walter Florey was born in Malvern, a southern suburb of Adelaide, South Australia, on 24 September 1898. His surname rhymes with "sorry". He was the only son of Joseph Florey, a bootmaker from Oxfordshire in England, who as a boy moved to London where Florey's grandfather established a bootmaking business. Joseph Florey's first wife was Charlotte Ames, with whom he had two daughters, Charlotte, who was born in 1880, and Anne, who was born in 1882. After his wife contracted pulmonary tuberculosis, the family emigrated to South Australia, where it was hoped that the climate would be more congenial. Her health gradually declined and she died in April 1886. Joseph Florey established his own bootmaking business in Adelaide, and married Bertha Mary Waldham, the daughter of his housekeeper. Their first child together, Hilda, was born on 6 September 1890. She became a bacteriologist and a pioneer of laboratory medicine. A second daughter, Valetta, was born in 1891. Thus, Florey had two older sisters and two older half-sisters. In 1906, the family moved to "Coreega", a mansion in the Adelaide suburb of Mitcham. Florey attended Unley Park School, a local private school, taking the two-mile (3.2 km) trip to school each day in a horse-drawn tram with Mollie Clampett, a friend who lived in the rectory adjacent to Coreega. At school he acquired the lifelong nickname "Floss", this being, like "Florrie", a common diminutive form of "Florence". He transferred to Kyre College, a private boys' school, in 1908.
The area under the effect curve (AUEC) is an integral of the effect of a drug over time, estimated as a previously-established function of concentration. It was proposed to be used instead of AUC in animal-to-human dose translation, as computer simulation shows that it could cope better with half-life and dosing schedule variations than AUC. This is an example of a PK/PD model, which combines pharmacokinetics and pharmacodynamics. Cmax (pharmacology) Cmean (pharmacology) "Area Under Curve" of the Receiver operating characteristic
Sources: en.wikipedia.org
A central Food Production Committee, set up in early 1942, organised the conscripted labourers and attempted to help the white farmers to grow all the crops they could. Maize production grew by 40% between 1942 and 1944, the potato harvest doubled and the onion crop grew sixfold by the end of the war. Production of the colony's most important cash crop, tobacco, was high throughout the war, averaging about 40 million pounds (18 million kg) annually. The number of cattle slaughtered by the beef industry increased by 134%, from 71,000 head in 1937 to 160,000 head in 1945. Vegetable dehydration, one of the Food Production Committee's main initiatives, proved a great success, allowing Rhodesia to export many products to the UK that would previously have spoiled in transit. Southern Rhodesia also provided goods to the Eastern Group Supply Council, a body set up in 1940 to co-ordinate the build-up of war materiel in India and other British colonies and dominions east of Suez, with the goal of reducing the amount of supplies shipped from the UK. A Rhodesian officer, Brigadier E G Cook, was the group's deputy controller general. Between 1941 and 1945 Southern Rhodesia contributed large quantities of timber, leather goods, soap and building materials.
== Absorption, metabolism, and excretion == Tocotrienols and tocopherols, the latter including the stereoisomers of synthetic alpha-tocopherol, are absorbed from the intestinal lumen, incorporated into chylomicrons, and secreted into the portal vein, leading to the liver. Absorption efficiency is estimated at 51% to 86%, and that applies to all of the vitamin E family – there is no discrimination among the vitamin E vitamers during absorption. Bile is necessary for chylomicron formation, so disease conditions such as cystic fibrosis result in biliary insufficiency and vitamin E malabsorption. When consumed as an alpha-tocopheryl acetate dietary supplement, absorption is promoted when consumed with a fat-containing meal. Unabsorbed vitamin E is excreted via feces. Additionally, vitamin E is excreted by the liver via bile into the intestinal lumen, where it will either be reabsorbed or excreted via feces, and all of the vitamin E vitamers are metabolized and then excreted via urine. Upon reaching the liver, RRR-alpha-tocopherol is preferentially taken up by alpha-tocopherol transfer protein (α-TTP). All other forms are degraded to 2'-carboxethyl-6-hydroxychromane (CEHC), a process that involves truncating the phytic tail of the molecule, then either sulfated or glucuronidated. This renders the molecules water-soluble and leads to excretion via urine. Alpha-tocopherol is also degraded by the same process, to 2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychromane (α-CEHC), but more slowly because it is partially protected by α-TTP.
In the glycolytic pathway, 1,3-bisphosphoglycerate is dephosphorylated to form 3-phosphoglyceric acid in a coupled reaction producing two ATP via substrate-level phosphorylation. The single phosphate group left on the 3-PGA molecule then moves from an end carbon to a central carbon, producing 2-phosphoglycerate. This phosphate group relocation is catalyzed by phosphoglycerate mutase, an enzyme that also catalyzes the reverse reaction.
=== 90Sr === Strontium-90 has been used by the Soviet Union in terrestrial RTGs. 90Sr decays by β− decay into 90Y, which quickly β-decays again. It has a lower decay energy than 238Pu, but its shorter half-life of 28.8 years and lower atomic weight yield a power density for pure metal of 0.95 watts per gram. As 90Sr is a very reactive alkaline earth metal and a bone seeker that accumulates in bone-tissue due to its chemical similarity to calcium (once in the bones it can significantly damage the bone marrow, a rapidly dividing tissue), it is usually not used in pure form in RTGs. The most common form is the perovskite strontium titanate (SrTiO3) which is chemically nigh-inert and has a high melting point. While its Mohs hardness of 5.5 has made it ill-suited as a diamond simulant, it is of sufficient hardness to withstand some forms of accidental release from its shielding without too fine dispersal of dust. The downside to using SrTiO3 instead of the native metal is it reduces power density, as the TiO3 part of the material does not produce any decay heat. 90Sr has a high fission product yield in the fission of both 235U and 239Pu and is thus available in large quantities at a relatively low price if extracted from spent nuclear fuel. Starting from the oxide or the native metal, one pathway to obtaining SrTiO3 is to let it transform to strontium hydroxide in aqueous solution, which absorbs carbon dioxide from air to become less soluble strontium carbonate.
Sources: en.wikipedia.org
== Structure == Chloroeremomycin is composed of seven amino acids (three non-proteinogenic, and four proteinogenic) and three saccharide units. From N-terminus to C-terminus, the order is: Me-L-Leu, L-Tyr, D-Asn, D-4-hydroxyphenylglycine (HPG), L-HPG, D-Tyr, and D-3,5-dihydroxyphenylglycine (DHPG). When referring to specific amino acids, this article will reference the amino acid in the order it appears within the heptapeptide. Chloroeremomycin is glycosylated at aa4 with a Glc-(2→α1)-epivancosamine disaccharide and at aa6 with a D-BHT-(→α1)-epivancosamine saccharide. Some amino acids are modified prior to the completion of the heptapeptide (in cis) and some are modified after the heptapeptide is formed (in trans). During the synthesis of the heptapeptide, the stereocenters of aa3, aa4, aa6, and aa7 are changed from L to D. Both Tyr residues are hydroxylated and chlorinated after the amino acids have been incorporated to the growing polypeptide to form 4-chloro-β-hydroxytyrosine (BHT). The now-BHT residues are then crosslinked to the aa4 HPG through aryl-ether linkages. An aryl-aryl bond is formed between aa5 and aa7 at the aa5-C3 and aa7-C2 positions on the aromatic rings. Finally, the N-terminus Leu is methylated. In addition to the presence of D-amino acids, the molecule has atropisomer chemistry. The orientations of the chloro-substituted phenyl rings add another aspect of stereochemistry to the molecule.
== Function == FGFR1OP2, when fused with the fibroblast growth factor receptor 1 (FGFR1), is shown to cause myeloproliferative syndrome. The protein encoded by the FGFR1 gene belongs to the fibroblast growth factor receptor family. FGFRs usually contain an extracellular ligand binding domain, a single transmembrane domain, and an intracellular tyrosine kinase domain. The extracellular domain specifies which ligand the receptor will bind to and mediates ligand-induced receptor dimerization. When FGFR1OP2 is fused to FGFR1, it may exhibit constitutive kinase activity. Furthermore, FGFR1OP2 is possibly involved in some steps of the wound healing pathway.
Robert Thomas Dursley Stott. For services to the British Red Cross Society on the Isle of Man. June Street, Executive Manager, Dacorum Council for Voluntary Service. For services to the community. Richard Kenneth Swan. For services to Tourism. Geoffrey Trevor Theobald. For political and public service. David Geraint Price-Thomas, lately Under Secretary (Wales), Council of Welsh Districts. For services to Local Government in Wales. Joan Margaret Elizabeth Thompson, . For public service. Kenneth Trench, Chairman, Maxwell Pensioners' Action Group. For services to Pensions Legislation. Michael Victor Upson, , lately Grade 6, Foreign and Commonwealth Office. Derek Eustace Murray Walker, Director, Worldware. For services to Public Awareness of Aid Issues. Professor Herbert Wallace. For services to the community. Trevor Ward, lately Head of Aerodrome Standards Department, Civil Aviation Authority. For services to Aviation. Hugh Ingram Watson, , Commandant, Scottish Police College. Kathleen Watson, Business Requirements Analyst, Board of Inland Revenue. Michael Robert Clarkson Webb. For services to the community in Surrey. Anthony Barton Wells. For services to the Family Justice System. Patrick Whinney, , President, Guernsey Cheshire Home Foundation. For services to the community. Annarosa Whitehead. For services to the Women's Transport Service (First Aid Nursing Yeomanry). John Charles Williams, Secretary and Chief Executive, Institution of Electrical Engineers. For services to Electrical Engineering. William Gwyn Williams.
Lad's father, Shivaji, died when Santosh was 16 years old. He is married to Keerthi Lad; they have a son, Karan Lad. His 2023 election affidavit identifies him as a businessman/entrepreneur and identifies his spouse's occupation as homemaker.
=== Meteoritic quinones === A proposed alternative source to chemiosmotic energy developing across membranous structures is if an electron acceptor, ferricyanide, is within a vesicle and the electron donor is outside, quinones transported by carbonaceous meteorites pick up electrons and protons from the donor. They would release electrons across the lipid membrane by diffusion to ferricyanide within the vesicles and release protons which produces gradients above pH 2, the process is conducive to the development of proton gradients.
Sources: en.wikipedia.org
It acts as an agonist at both the GIP and GLP-1 receptors, two related class B G protein-coupled receptors. This dual activity distinguishes it from single-receptor GLP-1 agonists. The clinical consequences of engaging both receptors are still being characterized.
It is given by subcutaneous injection, generally on a weekly schedule. Dosing usually begins low and increases in steps to limit gastrointestinal side effects. Formulated product is supplied as a ready-to-use pen or vial in most markets.
No. Receptor engagement is documented, but how central appetite circuits, gut signals, and insulinotropic effects combine is incompletely resolved. Investigators continue to separate GIP-driven from GLP-1-driven contributions in animal and human models.
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.